Among 696 patients treated with a drug to prevent blood clots, 150 developed nausea. This document tests the claim that the rate of nausea (p) is 3% by comparing it to the observed rate using a significance level of 0.10. The null hypothesis is that the rate of nausea (p) equals 0.03, and the alternative hypothesis is that the rate is greater than 0.03.